Sage Therapeutics is a biopharmaceutical company dedicated to transforming the treatment of brain health disorders. The company focuses on developing novel medicines to impact conditions such as depression, neuropsychiatry, and neurology through its innovative research on GABA and NMDA receptors. With a commitment to patient advocacy and flexible work arrangements, Sage Therapeutics aims to lead in the development of next-generation medicines and improve global brain health.
CNS disorders β’ Neuroscience β’ Brain Health β’ Mental Health β’ brain disorders
November 1
GxP IT professional managing GxP system management at Sage Therapeutics.